AMR’s Implications for Australia and Globally: A review of recent pivotal initiatives
This summary explores how antimicrobial resistance (AMR) is framed within Health Technology Assessment (HTA) frameworks worldwide and Australia’s unique role in HTA reviews. It examines the pressing market failures hindering AMR investment and emphasises the pivotal economic role of vaccines in combatting AMR. Key points from the Political Declaration on AMR, endorsed at the United […]
Australia’s Vaccine Value Chain Conference Outputs
There is an identified need in Australia’s Vaccine Value Chain to boost vaccine development, translation, commercialisation and access. Globally, there are urgent calls for international collaboration in epidemic and pandemic preparedness research from the World Health Organisation, and calls for critical reforms to the R&D ecosystem for infectious diseases from the Wellcome Trust. Responding to […]
The Value of Vaccines: A Tale of Two Parts
Since the mid-20th century, vaccination has globally been an integral component of strategies to prevent and eradicate infectious diseases. Australia, like many countries, uses health technology assessment (HTA) processes to evaluate the clinical, cost-effectiveness and budget impact of medicines, including vaccines, to determine whether they get funded. Critically, HTA typically only measures patient health and […]
Immunisation Coalition – Enhancing adult vaccination coverage rates in Australia
This white paper examines the challenges and barriers to achieving higher rates of vaccination among Australian adults eligible for the National Immunisation Program (NIP), identifies priority areas for action and suggests evidence-based strategies to improve vaccine coverage rates.
Shot In The Arm: The Numbers Behind a Vaccine
Listen Here
